FILE:CVH/CVH-8K-20090129142421.txt.gz
EVENTS:	Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
TEXT:
ITEM: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
Date of report (Date of earliest event reported)
January 29, 2009 (January 23, 2009)
 
COVENTRY HEALTH CARE, INC.
(Exact name of registrant as specified in its charter).
 
 
 
 
6705 Rockledge Drive, Suite 900, Bethesda, Maryland 20817
(Address of principal executive offices) (Zip Code)
 
(301) 581-0600
(Registrants telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
Precommencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
Precommencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
(b)        On January 23, 2009, Dale B. Wolf resigned as President and Chief Executive Officer of Coventry Health Care, Inc. (the Company), effective as of January 30, 2009.
 
(c)        Effective as of January 30, 2009, Allen Wise, 66, has been named the Companys Chief Executive Officer. Mr. Wise served as the Companys President and Chief Executive Officer from 1996 through 2004 and served as its non-executive chairman from 2004 until December 10, 2008, when he was named Executive Chairman. The information required with respect to Mr. Wise pursuant to Regulation S-K under Item 5.02 of Form 8-K is incorporated by reference to the Companys proxy statement distributed in connection with its 2008 Annual Meeting of Stockholders and filed on April 4, 2008.
 
 
Signature(s)
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 


